Scientific Advisory Board| Multiple Sclerosis
Fred D. Lublin, M.D., Chairman
Dr. Lublin is Professor of Neurology at Mount Sinai School of Medicine, New York and Director of the newly endowed Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai. Dr. Lublin has had over twenty-five years of work in Multiple Sclerosis, both clinically and through basic science and clinical trial research. As a neuroimmunologist, Dr. Lublin has a special interest in immune functions and abnormalities affecting the nervous system. He was chairman of the National MS Society (USA) advisory committee on clinical trials of new drugs in Multiple Sclerosis and now chairs the National Multiple Sclerosis Society's Research Programs Advisory Committee. Dr. Lublin and his colleagues at the National MS Society (USA) have recently re-defined the clinical course definitions of MS using data from a survey of the international MS community.
Ludwig Kappos, M.D.
Dr. Kappos obtained his M.D. and a Diploma in Clinical Psychology from the University of Würzburg, Germany. In 1980, he went on to specialize in Neurology and Neuroimmunology. He became Deputy Chief, Division of Clinical Neurology, Max Planck Society Clinical Research Unit for Multiple Sclerosis at the University of Würzburg, Germany. Since1990 he has been Head of the Outpatient Department, of the Neurology/Neurosurgery. In 1994 he became Professor for Neurology and Clinical Neuroimmunology at the University of Basle, Switzerland. His research interests include immunological and molecular studies in neuroimmunological diseases, methodology and conduct of therapeutic studies mainly in the field of MS, standardization of clinical assessment, use of magnetic resonance tomography in elucidating the pathogenesis of inflammatory CNS disease as tool in monitoring therapeutic studies. He is key member in several committees and advisory boards of Organizations as well as active in the field of MS. His scientific output includes more than 340 original papers and reviews in scientific journals and books.
Robert P Lisak, M.D.
Dr. Lisak is Parker Webber Chair of Neurology, Professor and Chair of Neurology and Professor of Immunology and Microbiology at Wayne State University School of Medicine. He also serves as Neurologist-in-Chief at the Detroit Medical Center and Chief of Neurology at Harper University Hospital. He received his undergraduate degree from New York University and his MD from Columbia University. Dr Lisak trained in Internal Medicine at Montefiore Hospital and Bronx Municipal Medical Center (Albert Einstein College of Medicine) and in Neurology and Allergy and Immunology at the University of Pennsylvania, where he also served on the faculty for 15 years. Dr Lisak also was a Research Associate at the National Institute for Mental Health in Bethesda and was a Fulbright-Hays Senior Research Scholar at the University of London. He has a long term interest in basic, clinical and translational research in several neurological diseases including multiple sclerosis and related demyelinating diseases of the central nervous system, myasthenia gravis and demyelinating neuropathies.
Gary Cutter, Ph.D.
Dr. Cutter is Professor of Biostatistics and Head of the Section on Research Methods and Clinical Trials at the University of Alabama at Birmingham School of Public Health Department of Biostatistics. Dr. Cutter has directed numerous Coordinating Centers for national and international clinical trials and multiple cores on program projects and collaborative grants. His major research interests are in the design of clinical trials and epidemiological studies. He is currently directing the coordinating center of three NIH sponsored randomized clinical trials:, including the trial of Combination Therapy in Multiple Sclerosis . He is a reviewer for multiple journals, serves on numerous advisory as well as Data and Safety Monitoring Boards for NIH, Universities and Industry.
Stephen C. Reingold, Ph.D.
Dr. Reingold is President of Scientific and Clinical Review Associates, LLC., a consulting group that provides strategic guidance in scientific research, pharmaceutical and biotech product development and clinical trial design and implementation in neurology. Dr. Reingold has over 35 years of experience in biomedical research and administration focused on neuroscience. He obtained a Bachelors of Science degree with honors from the University of California, Berkeley, a doctorate in neurophysiology from Cornell University and undertook postdoctoral research and teaching at Princeton University. Beginning in 1983, he served with the National Multiple Sclerosis Society for 22 years where he was Vice President for Research Programs. His responsibilities there included directing, evaluating and managing the world’s largest private MS research and research training program (nearly $400 million in basic, clinical and applied research) at a time when the first disease-modifying therapies for MS were developed, and he served the Society as a communicator and public spokesperson on scientific and clinical issues. Dr. Reingold has extensive consultancy experience with industry, academic and foundation research programs and has over 60 relevant professional publications.
Frederik Barkhof, M.D., Ph.D.
Dr. Barkhof holds the chair in Neuro radiology at the VU Medical Centre in Amsterdam, Netherlands. He is co-director of the MS Research Center Amsterdam and has published more than 200 scientific papers on MS, mostly concerning the use of MRI and treatment trials. He is a leading expert in MRI imaging of multiple sclerosis and has been instrumental in clinical trial design for multiple treatment trials.
Jean-Pierre Boissel, M.D.
Dr. Boissel is Professor of Clinical Pharmacology since 1984 at the Claude Bernard University in Lyon. At the University he obtained degrees in statistics and genetic before his medical doctorship in 1969. He was Lecturer for Biochemistry (1966-1967), then Assistant Professor in Medical Genetics, (1970-1971) and Assistant Professor in Medical Statistics (1973-1974). Since 1974 he chairs the Department of Clinical Trial Methodology and Clinical Pharmacology of the Claude Bernard University.
He has made major contributions on methodology clinical trials. He has been involved in various ways in the drug registration process in France over the last three decades.
Aaron Miller, M.D.
Dr. Miller is widely recognized as a preeminent MS clinician and has been recruited to direct clinical affairs at the Corinne Goldsmith Dickinson Center for Multiple Sclerosis. In addition, he holds joint positions as Director of the Division of Neurology at Mount Sinai School of Medicine, New York and Director of the Multiple Sclerosis Care Center at Maimonides Medical Center in Brooklyn.
Dr. Miller is an active member of the American Academy of Neurology and the New York City chapter of the National Multiple Sclerosis Society, where he serves as Chairman of the Clinical Advisory Committee.
More Information
Click for more information on the following items:
Core Candidates:
Non-Core Candidates:
